These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17006527)

  • 1. Successful treatment with oral valganciclovir in immunocompetent infant with gastrointestinal manifestations of cytomegalovirus infection.
    Buonuomo PS; Maurizi P; Valentini P; Mastrangelo S; Lazzareschi I; Ridola V; Riccardi R
    J Perinatol; 2006 Oct; 26(10):648-9. PubMed ID: 17006527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
    Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A
    Transplant Proc; 2005 Sep; 37(7):3182-6. PubMed ID: 16213344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on hearing of oral valganciclovir for asymptomatic congenital cytomegalovirus infection.
    Yilmaz Çiftdogan D; Vardar F
    J Trop Pediatr; 2011 Apr; 57(2):132-4. PubMed ID: 20576693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial experience with oral valganciclovir for pre-emptive cytomegalovirus therapy after lung transplantation.
    Aigner C; Jaksch P; Winkler G; Czebe K; Taghavi S; Marta G; Klepetko W
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):480-4. PubMed ID: 16091875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fulminant cytomegalovirus myocarditis in an immunocompetent host: resolution with oral valganciclovir.
    Padala SK; Kumar A; Padala S
    Tex Heart Inst J; 2014 Oct; 41(5):523-9. PubMed ID: 25425988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary atresia and cytomegalovirus and response to valganciclovir.
    Shah I; Bhatnagar S
    Indian Pediatr; 2012 Jun; 49(6):484-6. PubMed ID: 22796690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful corneal autograft after clearance of anterior chamber cytomegalovirus with oral valganciclovir in a patient with multiple failed corneal allografts.
    Lusthaus JA; Kim P; Steller AK; Naing Z; Scott GM; Rawlinson WD; Robinson LP; McCluskey PJ; Wechsler AW
    Cornea; 2011 Sep; 30(9):1054-7. PubMed ID: 21673567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection in immunocompetent wheezy infants: the diagnostic value of CMV PCR in bronchoalveolar lavage fluid.
    Cinel G; Pekcan S; Ozçelik U; Alp A; Yalçın E; Doğru Ersöz D; Kiper N
    J Clin Pharm Ther; 2014 Aug; 39(4):399-403. PubMed ID: 25040449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valganciclovir treatment of primary cytomegalovirus pneumonitis in an immunocompetent adult.
    Snape SE; Venkatesan P
    BMJ Case Rep; 2011 Mar; 2011():. PubMed ID: 22707605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus encephalitis in immunocompetent infants: A 15-year retrospective study at a single center.
    Guo Y; Jiang L
    Int J Infect Dis; 2019 May; 82():106-110. PubMed ID: 30844517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective assessment of valganciclovir for the treatment of cytomegalovirus infection and disease in transplant recipients.
    Humar A; Siegal D; Moussa G; Kumar D
    J Infect Dis; 2005 Oct; 192(7):1154-7. PubMed ID: 16136456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Valganciclovir. Oral treatment of Cytomegalovirus infections].
    Kroes AC
    Ned Tijdschr Geneeskd; 2004 Jun; 148(25):1236-8. PubMed ID: 15301386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients.
    Len O; Gavaldà J; Aguado JM; Borrell N; Cervera C; Cisneros JM; Cuervas-Mons V; Gurguí M; Martin-Dávila P; Montejo M; Muñoz P; Bou G; Carratalà J; Torre-Cisneros J; Pahissa A;
    Clin Infect Dis; 2008 Jan; 46(1):20-7. PubMed ID: 18171208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal CMV in an elderly, immunocompetent patient.
    Fyock C; Gaitanis M; Gao J; Resnick M; Shah S
    R I Med J (2013); 2014 Jun; 97(6):53-6. PubMed ID: 24905377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Valganciclovir treatment in a CMV congenital infected infant with sensorineural hearing loss (SNHL) first detected at 4 months of age.
    Hilgendorff A; Daiminger A; Dangel V; Kreuder J; Geidel C; Reiss I; Enders G
    Klin Padiatr; 2009 Dec; 221(7):448-9. PubMed ID: 20013570
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of cytomegalovirus pneumonia with ganciclovir in an immunocompetent infant].
    Siret D; David V
    Arch Pediatr; 2002 May; 9(5):499-502. PubMed ID: 12053544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infantile spasms and cytomegalovirus infection: antiviral and antiepileptic treatment.
    Dunin-Wasowicz D; Kasprzyk-Obara J; Jurkiewicz E; Kapusta M; Milewska-Bobula B
    Dev Med Child Neurol; 2007 Sep; 49(9):684-92. PubMed ID: 17718825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological outcomes in symptomatic congenital cytomegalovirus-infected infants after introduction of newborn urine screening and antiviral treatment.
    Nishida K; Morioka I; Nakamachi Y; Kobayashi Y; Imanishi T; Kawano S; Iwatani S; Koda T; Deguchi M; Tanimura K; Yamashita D; Nibu K; Funakoshi T; Ohashi M; Inoue N; Iijima K; Yamada H
    Brain Dev; 2016 Feb; 38(2):209-16. PubMed ID: 26282917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in treating CMV.
    Proj Inf Perspect; 2000 Aug; (30):19. PubMed ID: 12171012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valganciclovir for congenital CMV infection: a pilot study on plasma concentration in newborns and infants.
    Galli L; Novelli A; Chiappini E; Gervaso P; Cassetta MI; Fallani S; de Martino M
    Pediatr Infect Dis J; 2007 May; 26(5):451-3. PubMed ID: 17468661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.